Published June 16, 2022 | Version v1
Dataset Open

Dolutegravir in Real Life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho

Authors/Creators

  • 1. (1) Swiss Tropical and Public Health Institute, Basel, Switzerland (2) Molecular Virology Group, Department of Biomedicine, Basel, Switzerland (3) University of Basel, Basel, Switzerland
  • 2. (4) SolidarMed, Partnerships for Health, Maseru, Lesotho
  • 3. SolidarMed, Partnerships for Health, Maseru, Lesotho
  • 4. (1) Swiss Tropical and Public Health Institute, Basel, Switzerland (3) University of Basel, Basel, Switzerland
  • 5. (1) Swiss Tropical and Public Health Institute, Basel, Switzerland (3) University of Basel, Basel, Switzerland (5) University Hospital Basel, Basel, Switzerland
  • 6. (1) Swiss Tropical and Public Health Institute, Basel, Switzerland (3) University of Basel, Basel, Switzerland (6) University of Maryland, College Park, MD, USA
  • 7. (2) Molecular Virology Group, Department of Biomedicine, Basel, Switzerland (3) University of Basel, Basel, Switzerland
  • 8. (1) Swiss Tropical and Public Health Institute, Basel, Switzerland (3) University of Basel, Basel, Switzerland (5) University Hospital Basel, Basel, Switzerland (§) Corresponding author

Description

Pseudonymized dataset for the accepted manuscript "Dolutegravir in Real Life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho"

Files

Files (1.5 MB)

Name Size Download all
md5:6b70d718fe8921e62449de8aa10ba414
1.5 MB Download